-
-
-
-
-
-
-
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
-
-
-
-
-
-
-
Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
-
-
-
-
-
-
Twist Bioscience Announces Pricing of a $100 Million Public Offering of Common Stock
-
-
-
-
-
-
-
Twist Bioscience Announces Proposed Public Offering of Common Stock
-
-
-
-
-
72,087 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

